Gout Signs And Symptoms | MIMS Malaysia

Malaysia
Search
Sign In

Rheumatology Search

Rheumatology

Rheumatology

Home News Diseases Conferences Special Reports Multimedia

GOUT

Gout is a condition that resulted from deposition of monosodium urate crystals in various tissues (eg joints, connective tissue, kidney).
The patient experiences acute and chronic arthritis, soft tissue inflammation, tophus formation, gouty nephropathy and nephrolithiasis.
Primary hyperuricemia is called when uric acid saturation arises without coexisting diseases or drugs that alter uric acid production and excretion.
While in secondary hyperuricemia there is an excessive uric acid production or diminished renal clearance that occurs as a result of a disease, drug, dietary product or toxin.

Signs and Symptoms

Introduction

Gout is a condition wherein increased uric acid or urate in the body, also called hyperuricemia, leads to deposition of monosodium urate monohydrate (MSU) crystals in various tissues (eg joints, connective tissue, kidney)
Hyperuricemia is a necessary precondition for the development of MSU crystal deposition but this has to be distinguished from gout, the clinical syndrome
Results in acute and chronic inflammation associated with changes in articular & periarticular structures
Affects up to 1-2% of adults & is the most common inflammatory arthritis in men

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!

Ticagrelor-aspirin combo improves graft patency rates 1 year post-CABG

Roshini Claire Anthony, 11 Jun 2018

Patients who received a combination of ticagrelor plus aspirin within 24 hours of undergoing coronary artery bypass grafting (CABG) had significantly improved saphenous vein graft patency rates 1 year post-procedure compared with those who only received aspirin, according to findings of the DACAB* trial.

Plasma xanthine oxidase activity tied to insulin resistance, liver dysfunction in T2DM with MetS

3 days ago

Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.